Czech National Bank Acquires 1,263 Shares of Revvity, Inc. (NYSE:RVTY)

Czech National Bank raised its holdings in shares of Revvity, Inc. (NYSE:RVTY) by 5.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 26,388 shares of the company’s stock after purchasing an additional 1,263 shares during the quarter. Czech National Bank’s holdings in Revvity were worth $2,945,000 at the end of the most recent reporting period.

A number of other large investors have also recently made changes to their positions in the stock. EdgePoint Investment Group Inc. bought a new position in Revvity in the second quarter worth approximately $209,221,000. Southpoint Capital Advisors LP bought a new position in shares of Revvity during the 3rd quarter worth $25,550,000. Janus Henderson Group PLC increased its stake in shares of Revvity by 1.7% during the third quarter. Janus Henderson Group PLC now owns 6,335,302 shares of the company’s stock valued at $809,332,000 after buying an additional 108,401 shares during the period. Holocene Advisors LP raised its holdings in shares of Revvity by 14.6% in the third quarter. Holocene Advisors LP now owns 725,917 shares of the company’s stock valued at $92,736,000 after acquiring an additional 92,240 shares in the last quarter. Finally, RGM Capital LLC lifted its stake in Revvity by 6.7% in the second quarter. RGM Capital LLC now owns 950,858 shares of the company’s stock worth $99,707,000 after acquiring an additional 59,994 shares during the period. 86.65% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

RVTY has been the topic of a number of research reports. Sanford C. Bernstein downgraded shares of Revvity from an “outperform” rating to a “market perform” rating and set a $130.00 target price on the stock. in a research report on Friday, January 10th. Robert W. Baird boosted their price objective on shares of Revvity from $136.00 to $138.00 and gave the stock an “outperform” rating in a research note on Tuesday, November 5th. Barclays dropped their target price on Revvity from $140.00 to $135.00 and set an “overweight” rating on the stock in a research report on Monday, November 25th. Bank of America raised Revvity from a “neutral” rating to a “buy” rating and set a $138.00 price target for the company in a research report on Friday, December 13th. Finally, Leerink Partners raised their price objective on Revvity from $130.00 to $135.00 and gave the company an “outperform” rating in a research report on Thursday, October 17th. Five research analysts have rated the stock with a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, Revvity has a consensus rating of “Moderate Buy” and a consensus price target of $132.46.

Insider Transactions at Revvity

In related news, insider Tajinder S. Vohra sold 5,492 shares of the business’s stock in a transaction on Tuesday, January 7th. The shares were sold at an average price of $116.81, for a total value of $641,520.52. Following the completion of the transaction, the insider now directly owns 19,652 shares in the company, valued at $2,295,550.12. The trade was a 21.84 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Corporate insiders own 0.60% of the company’s stock.

Revvity Trading Up 0.5 %

Shares of Revvity stock opened at $119.49 on Friday. The stock has a market cap of $14.54 billion, a PE ratio of 57.73, a price-to-earnings-growth ratio of 3.37 and a beta of 1.03. The firm has a fifty day moving average price of $115.02 and a 200 day moving average price of $117.34. Revvity, Inc. has a 1 year low of $97.32 and a 1 year high of $129.50. The company has a debt-to-equity ratio of 0.40, a current ratio of 3.56 and a quick ratio of 2.97.

Revvity (NYSE:RVTY) last released its quarterly earnings data on Monday, November 4th. The company reported $1.28 earnings per share for the quarter, beating analysts’ consensus estimates of $1.13 by $0.15. Revvity had a return on equity of 7.42% and a net margin of 9.34%. The business had revenue of $684.10 million during the quarter, compared to analyst estimates of $679.66 million. During the same quarter last year, the business posted $1.18 EPS. The company’s revenue was up 2.1% on a year-over-year basis. Equities research analysts predict that Revvity, Inc. will post 4.84 earnings per share for the current year.

Revvity Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, February 7th. Shareholders of record on Friday, January 17th will be issued a $0.07 dividend. This represents a $0.28 dividend on an annualized basis and a yield of 0.23%. The ex-dividend date of this dividend is Friday, January 17th. Revvity’s payout ratio is presently 13.53%.

Revvity declared that its board has authorized a share repurchase plan on Monday, November 4th that permits the company to repurchase $1.00 billion in shares. This repurchase authorization permits the company to buy up to 6.5% of its shares through open market purchases. Shares repurchase plans are usually a sign that the company’s board believes its shares are undervalued.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.